Pulsenmore Ltd.PLSM
Price (close)
$2.57
Market cap
$16.7M
P/E
—
Revenue (FY)
$40.0M
Net income
-$15.9M
Dividend yield
—
1-year total return
—
Net margin
-39.6%
Revenue growth
314.3%
Debt / equity
—
What Pulsenmore Ltd. does.
are an emerging medical device company focused on research, development, manufacture, marketing, and sale of innovative, non-invasive
portable ultrasound solutions that provide significant healthcare benefits by utilizing next-generation technology for home use. We currently
have two primary products, the Pulsenmore ES and the Pulsenmore FC, and an additional third portable ultrasound solution that is in earlier
Revenue and profit, by fiscal year.
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | — | $6.2M | $9.7M | $40.0M |
| Net income | — | -$58.6M | -$36.7M | -$15.9M |
| Free cash flow | — | -$53.6M | -$42.0M | -$33.0M |
More on PLSM.
- Pulsenmore Ltd. summary
- Pulsenmore Ltd. financial statements
- Pulsenmore Ltd. key metrics
- Pulsenmore Ltd. health scores and style box
- Pulsenmore Ltd. earnings
- Pulsenmore Ltd. dividends
- Pulsenmore Ltd. valuation
- Pulsenmore Ltd. ownership and insiders
- Pulsenmore Ltd. peers
Figures from Pulsenmore Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.